Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2012, Vol. 32 Issue (6): 125-130    DOI:
    
Analysis of Molecular Diagnostics and Individuation Treatment Aiming at Serious Diseases Topics in "Eleventh Five-Year Plan" National High Technology Research and Development Program
YU Zhen-hang, WANG De-ping
China National Center for Biotechnology Development, Beijing 100039, China
Download: HTML   PDF(542KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

A brief analysis about National High Technology Research and Development Program(863)molecular diagnostics and individuation treatment aiming at serious diseases topics in "Eleventh Five-Year Plan" was given. The details about topics plan, institutions carrying out the topics and representative research results were presented,maybe these informations are useful to scientific and technical workers.



Key wordsNational High Technology Research and Development Program      Molecular diagnostics      Individuation treatment      Serious diseases     
Received: 09 April 2012      Published: 25 June 2012
ZTFLH:  Q819  
Cite this article:

YU Zhen-hang, WANG De-ping. Analysis of Molecular Diagnostics and Individuation Treatment Aiming at Serious Diseases Topics in "Eleventh Five-Year Plan" National High Technology Research and Development Program. China Biotechnology, 2012, 32(6): 125-130.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2012/V32/I6/125

[1] Duan X, Yue W, Liu L, et al. Single-nucleotide polymorphism (SNP) genotyping using cationic conjugated polymers in homogeneous solution. Nat Protoc, 2009, 4(6): 984-991.
[2] Li D D, Wang L L, Deng R, et al. The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells. Oncogene, 2009, 28(6):886-898.
[3] Huang P Y, Hong M H, Zhang X, et al. C-KIT overexpression and mutation in nasopharyngeal carcinoma cell lines and reactivity of Imatinib on these cell lines. Chin J Cancer, 2010,29(2):131-135.
[4] Fu J F, Shi J Y, Zhao W L, et al. MassARRAY assay: a more accurate method for JAK2V617F mutation detection in Chinese patients with myeloproliferative disorders. Leukemia, 2008, 22(3):660-663.
[5] 于颖彦, 吕有勇. 胃癌病理分型和诊断标准的建议.中华病理学杂志, 2010, 39:266-269. Yu Y Y, Lv Y Y. Advice on molecular diagnostics and individuation treatment of gastric cancer. Chin J Pathol, 2010, 39:266-269.
[6] Hao Y, Yu Y, Wang L, et al. IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology. J Proteome Res, 2008, 7(9):3668-3677.
[7] Yang Y H, Deng H, Li W M, et al. Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling. Clin Cancer Res, 2008, 14(1):74-81.
[8] Xu X, Li W, Fan X, et al. Identification and characterization of a novel p42.3 gene as tumor-specific and mitosis phase-dependent expression in gastric cancer. Oncogene, 2007, 26(52):7371-7379.
[9] Zhang X W, Yan X J, Zhou Z R, et al. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science, 2010, 328(5975):240-243.